EVERSANA is a leading independent provider of global services to the life sciences industry, offering integrated solutions that span all stages of the product life cycle. The company's services are designed to deliver long-term, sustainable value for patients, prescribers, channel partners, and payers.
Company Overview
- Founded: 2009
- Headquarters: Chicago, IL, USA
- Employees: Approximately 6,000 as of 2023
- Clients: Serves more than 670 organizations, including innovative start-ups and established pharmaceutical companies
Service Offerings
EVERSANA's comprehensive suite of services addresses various challenges in the life sciences sector, including:
- Market Access and Pricing: Assisting clients in navigating complex market access landscapes and developing effective pricing strategies.
- Commercialization: Providing end-to-end commercialization services, from launch readiness to in-market product support.
- Patient Services: Offering patient support programs, specialty pharmacy services, and in-home nursing care to enhance patient outcomes.
- Data & Analytics: Utilizing advanced analytics to inform decision-making and improve product performance.
- Market Research & Insights: Delivering custom and syndicated research to help clients understand market dynamics and stakeholder decision-making processes.
Recent Developments
- European Expansion: In May 2021, EVERSANA strengthened its global market access and pricing leadership by expanding its operations in Europe, appointing key leaders to enhance its presence in the region.
- Partnerships: In July 2020, the company partnered with the Institute for Clinical and Economic Review (ICER) to advance standards for indirect treatment comparisons in health technology assessments.
- Acquisitions: EVERSANA has expanded its capabilities through strategic acquisitions, including the integration of Health Strategies Group in 2018, enhancing its market access research and insights portfolio.
Employee Experience
EVERSANA is recognized for its positive workplace culture. As of October 2024, 67% of employees reported it as a great place to work, compared to 57% at a typical U.S.-based company. Employees highlighted a welcoming environment, significant responsibilities, and a culture of mutual care.
Market Position
EVERSANA operates in the competitive life sciences services industry, with key competitors including Avalere Health and Indegene. The company's integrated service model and patient-centric approach distinguish it in the market.
